Every SEC Form 3/4/5 on record for this filer (CIK 1216068) — 6 issuers, 44 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| CERE | Cerevel Therapeutics Holdings, Inc. | Director | 2020-10-30 → 2024-08-05 | 9 | −$7M |
| DNA | Ginkgo Bioworks Holdings, Inc. | Director · lapsed | 2021-09-20 → 2024-06-14 | 9 | −$2M |
| TBIO | Telesis Bio Inc. | 10% owner · lapsed | 2023-06-08 → 2023-06-08 | 1 | — |
| QSI | Quantum-Si Inc | Director · lapsed | 2021-06-14 → 2022-05-13 | 3 | — |
| QTRX | Quanterix Corp | Director · lapsed | 2017-12-06 → 2021-06-08 | 11 | −$5M |
| GE | GENERAL ELECTRIC CO | Director · lapsed | 2015-07-01 → 2018-04-02 | 13 | $598,000 |
| Ticker | Date | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| DNA | 2024-05-16 | Sell | 265,000 | $0.83 | $219,950 | 5,515,364 |
| DNA | 2024-05-14 | Sell | 1,727,056 | $0.93 | $2M | 281,217 |
| CERE | 2023-06-15 | Sell | 200,000 | $34.43 | $7M | 402,326 |
4 of 6 issuers are covered and open a security page; the rest are on file here only.
